Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Astrana Health (ASTH)
NASDAQ:ASTH
ASTH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$29.08 - $63.20
Previous CloseN/A
Volume92.25K
Average Volume (3M)335.76K
Market Cap
$1.84B
Enterprise Value$2.72B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)28.7
Beta1.32
Next Earnings
Feb 27, 2025EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.30
Shares Outstanding49,120,033
10 Day Avg. Volume261,875
30 Day Avg. Volume335,762
Standard Deviation0.20
R-Squared0.10
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.28
Price to Cash Flow (P/CF)16.20
P/FCF Ratio17.30
Enterprise Value/Market Cap1.48
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit12.66
Enterprise Value/Ebitda19.61
Forecast
1Y Price Target
$48.50Price Target Upside35.93% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Astrana Health News
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceASTH achieved double-digit year-over-year revenue and EBITDA growth while generating positive free cash flow.
Growth OutlookManagement expects 25%+ revenue growth and 10%+ EBITDA margins to continue.
Strategic AcquisitionsThe acquisition of Prospect’s Medical Group is considered a rational move due to geographic adjacencies and almost identical business mix.
Bears Say
Financial ImpactASTH provided expectations of the financial impact of the CHS acquisition, including an expected $4m negative EBITDA impact.
Margin PressureAstrana faces margin headwinds from a challenging macro environment and its latest acquisitions, in addition to uncertainties on whether the company could replicate its success in California in new markets.
Reporting TransparencyASTH's current reporting disclosures lack details to fully assess the quarterly performance of each service line.
---
Ownership Overview
39.46% Insiders
16.99% Mutual Funds
1.18% Other Institutional Investors
19.83% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ASTH FAQ
What was Astrana Health’s price range in the past 12 months?
Astrana Health lowest stock price was $29.08 and its highest was $63.20 in the past 12 months.
What is Astrana Health’s market cap?
Astrana Health’s market cap is $1.84B.
When is Astrana Health’s upcoming earnings report date?
Astrana Health’s upcoming earnings report date is Feb 27, 2025 which is in 4 days.
How were Astrana Health’s earnings last quarter?
Astrana Health released its earnings results on Nov 07, 2024. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.309 by $0.021.
Is Astrana Health overvalued?
According to Wall Street analysts Astrana Health’s price is currently Undervalued.
Does Astrana Health pay dividends?
Astrana Health does not currently pay dividends.
What is Astrana Health’s EPS estimate?
Astrana Health’s EPS estimate is 0.1.
How many shares outstanding does Astrana Health have?
Astrana Health has 49,120,033 shares outstanding.
What happened to Astrana Health’s price movement after its last earnings report?
Astrana Health reported an EPS of $0.33 in its last earnings report, beating expectations of $0.309. Following the earnings report the stock price went down -20.515%.
Which hedge fund is a major shareholder of Astrana Health?
Currently, no hedge funds are holding shares in ASTH
---
Astrana Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$48.50 (35.93% Upside)
$48.50 (35.93% Upside)
Hedge Fund Trend
Increased
By 45.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.2%
Last 30 Days ▼ 0.8%
Last 30 Days ▼ 0.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.76%
12-Months-Change
Fundamentals
Return on Equity
9.62%
Trailing 12-Months
Asset Growth
19.76%
Trailing 12-Months
Company Description
Astrana Health
Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient, and physician alignment solutions. The company focuses on physicians providing medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The firm operates through the healthcare delivery segment. The healthcare delivery segment implements and operates innovative health care models to create a patient-centered, physician-centric experience. Apollo Medical Holdings was founded on November 1, 1985 and is headquartered in Alhambra, CA.
---
ASTH Company Deck
---
ASTH Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
Astrana Health demonstrated strong revenue growth and expanded its membership and full risk revenue. However, there were declines in net income and quarterly EBITDA, and challenges with Medicaid cost trends. The acquisition of Collaborative Health Systems presents both opportunities and short-term challenges.Read More>---
ASTH Stock 12 Month Forecast
Average Price Target
$48.50
▲(35.93% Upside)
Technical Analysis
Best Analysts Covering ASTH
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
+15.45%
reiterated a buy rating 5 months ago
Copying David Larsen's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +15.45% per trade.
---